US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Franklin Genomic Advancements ETF

43.42

+0.06330.15%

Volume:613

Turnover:26.63K

Market Cap:32.57M

PE:- -

High:43.42

Open:43.42

Low:43.42

Close:43.36

52wk High:43.42

52wk Low:29.50

Shares:750.00K

Float Shares:750.00K

Volume Ratio:0.93

T/O Rate:0.08%

Dividend:0.14

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Natera Co-founder, Director Sheena Jonathan Disposes of 1,500 Common Shares Worth $410,322.91

Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of 105,762 Common Shares Worth $2.39 Million

Natera Says Finalized Moldx Coverage Expands Prospera Surveillance Testing for Kidney, Heart, Lung Transplants

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64

Guardant Health is Maintained at Buy by Guggenheim

Ligand Pharmaceuticals Inc : Benchmark Raises Target Price to $335 from $275

THOMSON REUTERS

Guardant Health price target raised to $190 from $160 at Guggenheim

Natera Co-founder, Director Sheena Jonathan Sells 3,150 Shares Worth $835,835.18

Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Ligand Pharma (LGND)

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Annexon Biosciences (ANNX) and Guardant Health (GH)

Natera Inc : TD Cowen Raises Target Price to $325 from $280

THOMSON REUTERS

XOMA Royalty Corporation Completes Merger with Ligand Pharmaceuticals

Ligand Closes Acquisition of XOMA Royalty for $39 Per Share Cash

XOMA Royalty Announces Closing of Its Acquisition by Ligand

THOMSON REUTERS

Press Release: Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Madrigal Pharmaceuticals (MDGL) and Krystal Biotech (KRYS)

Krystal Biotech Inc : Bofa Global Research Raises Price Objective to $396 from $364

THOMSON REUTERS

Guardant Health is Maintained at Buy by Canaccord Genuity

Guardant Health price target raised to $205 from $135 at Canaccord

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Krystal Biotech (KRYS) and Denali Therapeutics (DNLI)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/HELX/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HELX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","market":"US","secType":"STK","nameCN":"Franklin Genomic Advancements ETF","latestPrice":43.4241,"timestamp":1787774400000,"preClose":43.3608,"halted":0,"volume":613,"delay":0,"changeRate":0.001459843914319045,"floatShares":750000,"shares":750000,"eps":0,"marketStatus":"Pre-Mkt","change":0.0633,"latestTime":"08-27 06:28:00 EDT","open":43.42,"high":43.4241,"low":43.42,"amount":26634.89904,"amplitude":0.000095,"askPrice":69.04,"askSize":100,"bidPrice":17.46,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787837400000},"marketStatusCode":1,"adr":0,"exchange":"CBOE","adjPreClose":43.4241,"sharesOutstanding":650000,"nav":43.432,"aum":32573853.77,"dividendRate":0.003316,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":43.42,"preClose":43.4241,"latestTime":"19:30 EDT","volume":9,"amount":390.8928,"timestamp":1787787003629,"change":-0.0041,"changeRate":-0.000094,"amplitude":0},"volumeRatio":0.933029132350639,"impliedVol":0.0892,"impliedVolPercentile":0.352},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","floatShares":750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.933029132350639,"shares":750000,"dividePrice":0.144,"high":43.4241,"amplitude":0.000095,"preClose":43.3608,"low":43.42,"week52Low":29.5,"pbRate":"--","week52High":43.4241,"institutionHeld":0,"latestPrice":43.4241,"eps":0,"divideRate":0.003316,"volume":613,"delay":0,"ttmEps":0,"open":43.42,"prevYearClose":36.3062,"prevWeekClose":43.11,"prevMonthClose":38.8312,"prevQuarterClose":39.9651,"fiveDayClose":42.8036,"twentyDayClose":38.8922,"sixtyDayClose":35.0506},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HELX\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HELX","amount":0.14334,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Franklin Genomic Advancements ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-08"},{"market":"US","date":"2021-12-30","symbol":"HELX","amount":0.003935,"defaultRemindTime":1640874600000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000},{"market":"US","date":"2021-12-13","symbol":"HELX","amount":0.114148,"defaultRemindTime":1639405800000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2021-12-21","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2020-12-14","symbol":"HELX","amount":0.005005,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2020-12-23","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HELX\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-23","value":0.005005,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-21","value":0.114148,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.003935,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-08","value":0.14334,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HELX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HELX\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652236851","title":"Natera Co-founder, Director Sheena Jonathan Disposes of 1,500 Common Shares Worth $410,322.91","url":"https://stock-news.laohu8.com/highlight/detail?id=2652236851","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652236851?lang=en_us&edition=fundamental","pubTime":"2026-07-18 09:05","pubTimestamp":1784336751,"startTime":"0","endTime":"0","summary":"Natera co-founder, Director Sheena Jonathan disposes of 1,500 common shares worth $410,322.91Natera director and co-founder Sheena Jonathan sold 1,500 common shares on July 15, 2026 at about $273 to $","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260718:nNDL9nvf8P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera Co-founder, Director Sheena Jonathan Disposes of 1,500 Common Shares Worth $410,322.91","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","LU2324357040.USD","LU2065170008.USD","HELX","LU2065169927.USD","NTRA","GNOM","LU2065171311.SGD","LU0012050646.USD","LU2264538146.SGD","LU1064131342.USD","LU0963586101.USD","BK4139","LU0106261612.USD","LU2065731478.USD","LU0345770308.USD","LU2065171402.SGD","LU1988902786.USD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652330702","title":"Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of 105,762 Common Shares Worth $2.39 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2652330702","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652330702?lang=en_us&edition=fundamental","pubTime":"2026-07-18 07:24","pubTimestamp":1784330673,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Chief People Officer Francis Lo disposes of 105,762 common shares worth $2.39 millionAdaptive Biotechnologies Chief People Officer Francis Lo sold 105,762 shares on July 15 at","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDL2NV8mT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of 105,762 Common Shares Worth $2.39 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT","BK4121","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652420159","title":"Natera Says Finalized Moldx Coverage Expands Prospera Surveillance Testing for Kidney, Heart, Lung Transplants","url":"https://stock-news.laohu8.com/highlight/detail?id=2652420159","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652420159?lang=en_us&edition=fundamental","pubTime":"2026-07-17 06:37","pubTimestamp":1784241425,"startTime":"0","endTime":"0","summary":"Natera says finalized MolDx coverage expands Prospera surveillance testing for kidney, heart, lung transplantsNatera flagged a final MolDx local coverage determination (L40060) expanding Medicare cove","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL6Wxmx2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2264538146.SGD","LU2065170008.USD","LU1988902786.USD","LU0963586101.USD","NTRA","LU2065169927.USD","LU2065171402.SGD","HELX","LU0053671581.USD","LU0345770993.USD","LU1064131342.USD","LU0345770308.USD","LU2065171311.SGD","LU0106261612.USD","BK4139","LU2324357040.USD","LU2065731478.USD","LU0012050646.USD","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652278224","title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64","url":"https://stock-news.laohu8.com/highlight/detail?id=2652278224","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652278224?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:57","pubTimestamp":1784235433,"startTime":"0","endTime":"0","summary":"Guardant Health director Tariq Musa disposes of 116 common shares worth $18,941.64Guardant Health director Tariq Musa cut his stake to 11,182 shares following a sale disclosed in a Form 4.Musa sold 11","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDLc18J55:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","BK4535","LU0109394709.USD","EKG","HELX","GH","PTH","BK4585","BK4588","GDOC","LU0320765992.SGD","LU0889565916.HKD","BK4551","GNOM","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651290441","title":"Guardant Health is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2651290441","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651290441?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:10","pubTimestamp":1784203800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJuly 16, 2026 08:10 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELX","BK4585","LU0320765992.SGD","PTH","LU0109394709.USD","BK4551","GNOM","LFSC","GH","LU0889565916.HKD","BK4588","EKG","GDOC","BK4535","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651446790","title":"Ligand Pharmaceuticals Inc : Benchmark Raises Target Price to $335 from $275","url":"https://stock-news.laohu8.com/highlight/detail?id=2651446790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651446790?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:20","pubTimestamp":1784200830,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nFWN43I17S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","LU1559883803.SGD","HELX","LGND","LU0566484027.USD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651344620","title":"Guardant Health price target raised to $190 from $160 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2651344620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651344620?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:00","pubTimestamp":1784199651,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Guardant Health (GH) to $190 from $160 and keeps a Buy rating on the shares. The firm says its Q2 web ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-160-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-160-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","BK4196","BK4551","LU0889565916.HKD","HELX","EKG","BK4535","BK4585","GDOC","GH","BK4588","GNOM","PTH","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651925264","title":"Natera Co-founder, Director Sheena Jonathan Sells 3,150 Shares Worth $835,835.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2651925264","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651925264?lang=en_us&edition=fundamental","pubTime":"2026-07-16 09:05","pubTimestamp":1784163957,"startTime":"0","endTime":"0","summary":"Natera co-founder, director Sheena Jonathan sells 3,150 shares worth $835,835.18Natera director and co-founder Sheena Jonathan sold 3,150 common shares on July 13, 2026 at about USD 262.72 to USD 268.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL7z6S8f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera Co-founder, Director Sheena Jonathan Sells 3,150 Shares Worth $835,835.18","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0012050646.USD","NTRA","LU0106261612.USD","LU1988902786.USD","BK4139","LU0963586101.USD","LU2264538146.SGD","LU0345770308.USD","LU0345770993.USD","GNOM","HELX","LU1064131342.USD","LU2065171402.SGD","LU0053671581.USD","LU2065171311.SGD","LU2065170008.USD","LU2065169927.USD","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651450617","title":"Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Ligand Pharma (LGND)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651450617","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651450617?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:40","pubTimestamp":1784115615,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX) and Ligand Pharma (LGND) wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-boston-scientific-bsx-ligand-pharma-lgnd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-boston-scientific-bsx-ligand-pharma-lgnd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0225283273.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","LU1559883803.SGD","SG9999001176.SGD","LU2357305700.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0566484027.USD","LU2244417387.USD","LU0823417737.USD","LU0266013472.USD","LU1023059063.AUD","LU1791710400.SGD","SG9999001176.USD","LU1153585028.USD","LU1989772840.SGD","LU0138981039.USD","BK4504","BK4007","LU0122379950.USD","LU2362541513.USD","LU0251132253.USD","LU1720051108.HKD","LU2506952170.USD","LU1291159041.SGD","IE0009355771.USD","LU0432979614.USD","LU0882574055.USD","LGND","BK4139","LU2506951958.HKD","LU2324357040.USD","LU0823416689.USD","LU0353189680.USD","LU1791710582.SGD","LU1989772923.USD","LU0114720955.EUR","SGXZ57979304.SGD","LU2362540622.SGD","LU0528227936.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0238689110.USD","LU2491050071.SGD","LU2242649171.HKD","LU0345769128.USD","BSX","SG9999013999.USD","LU1718418525.SGD","LU1983299246.USD","LU0187121727.USD","LU1061106388.HKD","LU0077335932.USD","LU0345769631.USD","BK4588","LU2491050154.USD","BK4082","LU0011850046.USD","LU2265009873.SGD","LU1366192091.USD","LU0823417653.USD","LU1989764664.SGD","LU2506951875.HKD","LU0950375773.USD","LU2491049909.HKD","LU0267386448.USD","LU0353189763.USD","BK4581","LU0048584097.USD","BK4585","LU2112291526.USD","LU1804176565.USD","LU1989771016.USD","IE0009354923.USD","LU1548497426.USD","LU1989764748.USD","LU2506952097.USD","HELX","LU2087625088.SGD","LU1720051017.SGD","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651452589","title":"Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Annexon Biosciences (ANNX) and Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651452589","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651452589?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:40","pubTimestamp":1784112028,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Merck & Company (MRK), Annexon Biosciences (ANNX) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-annexon-biosciences-annx-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-annexon-biosciences-annx-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999002224.SGD","LU0965509010.AUD","LU1585245621.USD","BK4533","LU0980610538.SGD","LU2461242641.AUD","PPH","LU1093756325.SGD","IXJ","BK4516","BK4550","LFSC","LU1941712264.USD","LU2361044865.SGD","LU1974910355.USD","IE00B1BXHZ80.USD","LU0238689110.USD","IE00BN8TJ469.HKD","LU0130102774.USD","LU1035773651.USD","LU2106854487.HKD","RXL","BK4585","LU0265550946.USD","BK4551","LU1917777945.USD","LU1069347547.HKD","LU0130517989.USD","SG9999001176.USD","IHE","LU0477156953.USD","LU2324357040.USD","LU2491050071.SGD","SG9999013999.USD","LU0432979614.USD","LU2125154935.USD","LU1201861249.SGD","LU1023059063.AUD","LU1037948897.HKD","LU1699723380.USD","SG9999014575.USD","IE000M9KFDE8.USD","IYH","LU1162221912.USD","ANNX","MRK","LU0006306889.USD","LU1061106388.HKD","BK4588","LU1934455277.USD","LU0234572021.USD","IE0009355771.USD","LU1989771016.USD","LU0868494708.USD","LU1037948541.HKD","LU0942090050.USD","PAWZ","SGXZ57979304.SGD","VHT","LU0211331839.USD","LU1929549753.HKD","LU2357627491.SGD","LU2491050154.USD","GDOC","LU2125154778.USD","LU2433249047.HKD","SG9999015341.SGD","LU1430594728.SGD","LU0889565916.HKD","LU2361044949.HKD","SG9999015358.SGD","LU0070302665.USD","LU1989772840.SGD","LU1291159041.SGD","LU1066051225.USD","LU1116320901.HKD","LU0320765992.SGD","LU1923622614.USD","LU1989772923.USD","BK4007","LU0965509283.SGD","LU1934455194.USD","LU2361045086.USD","LU0098860793.USD","LU0648001328.SGD","LU1057294990.SGD","BK4196","IE00BJJMRZ35.SGD","LU0985320562.USD","LU0859254822.USD","IE00BLSP4239.USD","LU2125909593.SGD","LU0265550359.USD","LU1066051498.USD","GNOM","IE00BSNM7G36.USD","BK4535","SG9999001176.SGD","LU1934455863.HKD","FTXH","LU1116320737.USD","LU0320765489.SGD","BK4139","GH","LU1571399168.USD","LU2023250843.SGD","IE0002141913.USD","LU0868494617.USD","LU0965509101.SGD","LU0106261372.USD","LU0122379950.USD","SG9999001440.SGD","LU0203347892.USD","LU0266013472.USD","BMED","LU1941712348.USD","IE00BJT1NW94.SGD","LU1983299246.USD","LU2089984988.USD","BK4534","LU0124676726.USD","LU2112291526.USD","SG9999014542.SGD","LU0058720904.USD","LU0320765646.SGD","IE00B2B36J28.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU2491049909.HKD","LU0109394709.USD","LU0203345920.USD","LU2125909247.SGD","SG9999014559.SGD","SG9999014567.USD","LU1093756168.USD","SG9999002232.USD","LU1066051811.HKD","HRTS","LU2360032135.SGD","LU2468319806.SGD","LU0289739699.SGD","LU0965508806.USD","LU2023250504.SGD","PTH","EKG","LU0208291251.USD","FHLC","LU0861579265.USD","LU0689626769.HKD","HELX","BK4559","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","JDOC","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451247","title":"Natera Inc : TD Cowen Raises Target Price to $325 from $280","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451247","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451247?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:08","pubTimestamp":1784110087,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0QG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","BK4139","LU2065171402.SGD","LU0106261612.USD","LU1988902786.USD","LU0012050646.USD","LU2065170008.USD","LU2065169927.USD","LU2264538146.SGD","GNOM","LU2324357040.USD","LU1064131342.USD","NTRA","LU0345770308.USD","LU2065731478.USD","HELX","LU0963586101.USD","LU2065171311.SGD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651453502","title":"XOMA Royalty Corporation Completes Merger with Ligand Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2651453502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651453502?lang=en_us&edition=fundamental","pubTime":"2026-07-15 16:01","pubTimestamp":1784102486,"startTime":"0","endTime":"0","summary":"The latest update is out from XOMA Royalty Corporation ( ($XOMA) ). On July 14, 2026, XOMA Royalty Corporation completed its previously announced m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xoma-royalty-corporation-completes-merger-with-ligand-pharmaceuticals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xoma-royalty-corporation-completes-merger-with-ligand-pharmaceuticals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XOMA","IE0009354923.USD","BK4007","LGND","HELX","LU0566484027.USD","LU1559883803.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651485106","title":"Ligand Closes Acquisition of XOMA Royalty for $39 Per Share Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2651485106","media":"Reuters","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651485106?lang=en_us&edition=fundamental","pubTime":"2026-07-14 21:01","pubTimestamp":1784034064,"startTime":"0","endTime":"0","summary":"Ligand closes acquisition of XOMA Royalty for $39 per share cashLigand Pharmaceuticals completed its acquisition of XOMA Royalty, buying all outstanding common shares.Stockholders received USD 39 per ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL5l2sMG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","IE00BGHQF748.EUR","NDAQ","LU2210149790.SGD","IE00BKPKM429.USD","BK4139","LU2095319765.USD","SG9999014021.USD","SG9999014039.USD","BK4007","BCDF","IE0009354923.USD","IE00B64PRP62.GBP","SG9999014005.SGD","HELX","BK4112","SG9999014013.SGD","LU2210150020.SGD","XOMA","LU0566484027.USD","BK4585","BK4588","LU0314104364.USD","LGND","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651069611","title":"XOMA Royalty Announces Closing of Its Acquisition by Ligand","url":"https://stock-news.laohu8.com/highlight/detail?id=2651069611","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651069611?lang=en_us&edition=fundamental","pubTime":"2026-07-14 21:00","pubTimestamp":1784034006,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA9RFBHY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1559883803.SGD","BK4007","IE0009354923.USD","LGND","HELX","BK4139","XOMA","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651106139","title":"Press Release: Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2651106139","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651106139?lang=en_us&edition=fundamental","pubTime":"2026-07-14 21:00","pubTimestamp":1784034000,"startTime":"0","endTime":"0","summary":"Acquisition adds seven commercial products including VABYSMO(R) (faricimab-svoa), OJEMDA(TM) (tovorafenib), and MIPLYFFA(R) (arimoclomol), and more than 100 development and commercial-stage assets, cr","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0330918003.SGD","BK4022","BK4585","LU0788109121.HKD","BK4161","BK4604","BK4555","SG9999001143.SGD","XOMA","LU0724618789.USD","LU0498741890.SGD","03160","LU0300736062.USD","LU0345780521.USD","LU0788108826.HKD","BK4099","LU0496367417.USD","LU0654597011.USD","BK4588","LU0566484027.USD","LU0612318971.USD","BK4232","LU0630314457.HKD","BU","IE0009354923.USD","LU0345781412.USD","TM","LU1559883803.SGD","LU0345780281.USD","LU1430597077.USD","HELX","B","LU0498741114.HKD","LU0368265764.SGD","R","BK4007","LU0345780950.USD","LU0055631609.USD","BK4017","LU0075056555.USD","LGND","SG9999002521.SGD","LU1023059493.AUD","BK4139","LU0612318385.USD","LU0300736492.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105476","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Madrigal Pharmaceuticals (MDGL) and Krystal Biotech (KRYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105476?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:40","pubTimestamp":1784032839,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alnylam Pharma (ALNY), Madrigal Pharmaceuticals (M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-alnylam-pharma-alny-madrigal-pharmaceuticals-mdgl-and-krystal-biotech-krys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-alnylam-pharma-alny-madrigal-pharmaceuticals-mdgl-and-krystal-biotech-krys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU0320765992.SGD","BK4588","LU0882574055.USD","XBI","BK4548","PBE","LU0114720955.EUR","MDGL","LU0128526141.USD","LU0109394709.USD","BK4581","ALNY","LU0029874061.USD","LU0889565916.HKD","KRYS","XLV","BK4139","HELX","LABU","PSCH","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651810563","title":"Krystal Biotech Inc : Bofa Global Research Raises Price Objective to $396 from $364","url":"https://stock-news.laohu8.com/highlight/detail?id=2651810563","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651810563?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:31","pubTimestamp":1784032302,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G10M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HELX","KRYS","BK4139","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651103511","title":"Guardant Health is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2651103511","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651103511?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:05","pubTimestamp":1784030700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJuly 14, 2026 08:05 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4588","LFSC","PTH","GH","LU0320765992.SGD","EKG","GDOC","BK4551","HELX","LU0109394709.USD","GNOM","BK4535","LU0889565916.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651177472","title":"Guardant Health price target raised to $205 from $135 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2651177472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651177472?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:56","pubTimestamp":1784026600,"startTime":"0","endTime":"0","summary":"Canaccord analyst Kyle Mikson raised the firm’s price target on Guardant Health (GH) to $205 from $135 and keeps a Buy rating on the shares. The fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-205-from-135-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-205-from-135-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HELX","BK4585","LU0320765992.SGD","PTH","LU0109394709.USD","BK4551","GNOM","LFSC","GH","LU0889565916.HKD","BK4588","EKG","GDOC","BK4535","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651092112","title":"Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Krystal Biotech (KRYS) and Denali Therapeutics (DNLI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651092112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651092112?lang=en_us&edition=fundamental","pubTime":"2026-07-13 22:01","pubTimestamp":1783951267,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Genmab (GMAB), Krystal Biotech (KRYS) and Denali Therapeutics (DN...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-krystal-biotech-krys-and-denali-therapeutics-dnli-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-krystal-biotech-krys-and-denali-therapeutics-dnli-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4137","BK4588","HELX","KRYS","BK4139","LU0029874061.USD","BK4535","DNLI","BK4585","HCSG","BK4548","LABU","LU0128526141.USD","XLV","PSCH","GMAB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}